Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v1-EN
Language English English
Date Updated 2017-06-17 2017-05-04
Drug Identification Number 02087286 02087286
Brand name ALKERAN ALKERAN
Common or Proper name Alkeran Injection / Melphalan Alkeran Injection / Melphalan
Company Name ASPEN PHARMACARE CANADA INC. ASPEN PHARMACARE CANADA INC.
Ingredients MELPHALAN BUFFER SOLUTION MELPHALAN BUFFER SOLUTION
Strength(s) 50MG 10ML 50MG 10ML
Dosage form(s) KIT POWDER FOR SOLUTION SOLUTION KIT POWDER FOR SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRA-ARTERIAL INTRAVENOUS INTRA-ARTERIAL
Packaging size 1 vial 1 vial
ATC code L01AA L01AA
ATC description ALKYLATINGAGENTS ALKYLATINGAGENTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2017-06-01 2017-06-01
Actual start date
Estimated end date 2017-06-19 2017-06-19
Actual end date 2017-06-16
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Product released as of June 16, 2017 Delay in shipping of the drug, no stock out foreseen. we ask hospitals to postpone non-urgent treatments and use Alkeran on a case by case basis for this short period. For any question, please contact Robin Lombardot at rlombardot@ca.aspenpharma.com
Health Canada comments